Literature DB >> 21040506

Genetic diversity of human zoonotic leishmaniasis in Iberian Peninsula.

S Cortes1, C Chicharro, I Cruz, J M Cristovão, C Cañavate, L Campino.   

Abstract

Leishmaniasis caused by Leishmania (Leishmania) infantum is a zoonotic disease endemic in South Europe, from Portugal to the Middle East. The aim of the present study was to investigate the genetic diversity of L. infantum parasites in Iberian Peninsula. Twenty-four L. infantum strains isolated from immunocompetent patients with leishmaniasis from several localities of Portugal and Spain were studied. The use of kinetoplast DNA-PCR-restriction fragment length polymorphism as a molecular marker revealed intra-specific variation. No association was found between genotype and clinical form of the disease or patients age group. Two main clusters were identified with this marker: (i) zymodeme MON-1 strains and (ii) non-MON-1 strains. However, no association was found between strains variability and geographical distribution suggesting that parasite populations of different regions in the Iberian Peninsula are homogenous.
© 2010 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040506     DOI: 10.1111/j.1863-2378.2010.01374.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  2 in total

1.  Population Structure of Leishmania tropica Causing Anthroponotic Cutaneous Leishmaniasis in Southern Iran by PCR-RFLP of Kinetoplastid DNA.

Authors:  Mohammad Amin Ghatee; Hossein Mirhendi; Masoud Marashifard; Zahra Kanannejad; Walter R Taylor; Iraj Sharifi
Journal:  Biomed Res Int       Date:  2018-06-06       Impact factor: 3.411

2.  KDNA genetic signatures obtained by LSSP-PCR analysis of Leishmania (Leishmania) infantum isolated from the new and the old world.

Authors:  Janaína Sousa Campos Alvarenga; Carla Maia Ligeiro; Célia Maria Ferreira Gontijo; Sofia Cortes; Lenea Campino; Annamaria Ravara Vago; Maria Norma Melo
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.